1334
S. Bondock et al.
150.7 (C4-pyrazole), 156.9 (C4-thiazole), 162.1 (C¼O), 165.8
(C2-thiazole) ppm; MS (EI, 70 eV): m=z (%) ¼ 375 (Mþ, 7.8),
317 (9.3), 269 (5.8), 202 (9.3), 97 (26), 57 (100), 69 (69.6).
9Ar–H, pyrazole-H5), 8.23 (s, NH2), 8.34 (s, CH¼N), 9.6 (s,
NH) ppm; 13C NMR (CDCl3): ꢁ ¼ 21.0 (CH3), 113.2 (C4-
pyrazole), 119.6 (2CHAr), 125.2 (2CHAr), 126.9 (2CHAr),
128.1 (CHAr), 129.3 (2CHAr), 134.8 (CAr), 137.8 (C3-pyra-
zole), 138.7 (CAr), 140.5 (CAr), 144.3 (C5-pyrazole), 149.6
(CH¼N), 177.4 (C¼S) ppm.
4-(2-(4-Methoxyphenyl)hydrazono)-3-methyl-1-(4-phenyl-
thiazol-2-yl)-1H-pyrazol-5(4H)-one (4c, C20H17N5O2S)
Reddish brown crystals; yield 1.66g (85%); mp 184–185ꢁC;
IR (KBr): ꢀꢀ¼ 3167 (NH), 1656 (C¼O), 1604 (C¼N) cmꢀ1
;
1-((3-(4-Nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-
thiosemicarbazide (10c, C17H14N6O2S)
1H NMR (DMSO-d6): ꢁ ¼ 2.3 (s, CH3), 3.76 (s, OCH3),
7.00–7.62 (m, 5Ar–H, thiazole-H5), 7.78–7.80 (d, J ¼ 7.5 Hz,
4-CH3O–C6H4), 7.93–7.95 (d, J ¼ 7.5 Hz, 4-CH3O–C6H4),
13.3 (s, NH) ppm; 13C NMR (DMSO-d6): ꢁ ¼ 11.9 (CH3),
51.8 (OCH3), 107.2 (C5-thiazole), 119.7 (2CHAr), 127.1
(2CHAr), 128.0 (CHAr), 128.9 (2CHAr), 130.3 (2CHAr), 133.8
(C3-pyrazole), 134.9 (CAr), 137.4 (CAr), 140.6 (CAr), 151.3 (C4-
pyrazole), 155.8 (C4-thiazole), 164.2 (C¼O), 166.7 (C2-thia-
zole) ppm.
Deep yellow powder; yield 1.10g (98%); mp 294–295ꢁC;
IR (KBr): ꢀꢀ¼ 3174–3360 (NH2), 3136 (NH), 1597 (C¼N)
1
cmꢀ1; H NMR (DMSO-d6): ꢁ ¼ 7.42–8.0 (m, 9Ar–H, pyra-
zole-H5), 8.42 (s, NH2), 9.23 (s, CH¼N), 11.34 (s, NH) ppm;
13C NMR (DMSO-d6): ꢁ ¼ 115.2 (C4-pyrazole), 120.1
(2CHAr), 125.0 (CHAr), 127.8 (2CHAr), 129.1 (2CHAr), 129.4
(2CHAr), 135.8 (CAr), 137.8 (C3-pyrazole), 138.9 (CAr), 140.5
(CAr), 144.3 (C5-pyrazole), 150.6 (CH¼N), 178.4 (C¼S) ppm.
Ethyl 5-formyl-3-methyl-1-(4-phenylthiazol-2-yl)-1H-
pyrazole-4-carboxylate (8, C17H15N5S)
Synthesis of 2-(arylidenehydrazino)-4-phenylthiazoles
11a–11c
In a 50cm3 round bottom flask 0.6cm3 phosphourous oxy-
chloride (4mmol) were gradually added to well cooled (0–
5ꢁC) 20cm3 DMF with stirring for 30 min, then 0.6g 2
(2mmol) were added in one portion. The reaction mixture
was allowed to rise at room temperature for 5 min, then
refluxed on a water bath at 75ꢁC for 2 h. The reaction mixture
was cooled, poured into crushed ice; the solid product that
formed was filtered off, dried, and recrystallized from EtOH
to give 8. Yellow crystals; yield 0.40 g (58%); mp 140–141ꢁC;
A mixture of thiosemicarbazone 9 (2mmol) and 398 mg phe-
nacyl bromide (2mmol) was ball-milled at room temperature
for 60 min. After drying at 0.01 bar at 80ꢁC, a quantitative
yield of thiazoleꢂ HBr 11a–11c was obtained. The free base
11a–11c was recovered by washing the fine powder of the
HBr salt with 5% aqueous Na2CO3 solution followed by H2O
and drying in vacuum.
IR (KBr): ꢀꢀ¼ 1704, 1695 (2C¼O), 1600 (C¼N) cmꢀ1
;
2-((1,3-Diphenyl-1H-pyrazol-4-yl)methylene)-1-(4-phenyl-
thiazol-2-yl)-hydrazine (11a, C25H19N5S)
1H NMR (CDCl3): ꢁ ¼ 1.40 (t, J ¼ 7.5 Hz, CH3), 2.57 (s,
CH3), 4.36 (q, J ¼ 7.5 Hz, OCH2), 7.27–7.93 (m, 5Ar–H, thi-
azole-H5), 9.84 (s, CHO) ppm; 13C NMR (CDCl3): ꢁ ¼ 13.1
(CH3), 13.8 (CH3), 62.1 (OCH2), 105.1 (C5-thiazole), 112.6
(C4-pyrazole), 126.3 (2CHAr), 128.1 (CHAr), 128.5 (2CHAr),
136.3 (CAr), 137.8 (C3-pyrazole), 146.2 (C5-pyrazole),
156.3 (C4-thiazole), 165.5 (C¼O), 167.6 (C2-thiazole),
178.8 (HC¼O) ppm.
Brown powder; yield 0.82 (98%); mp 163–164ꢁC (Ref. [25]
162ꢁC); IR (KBr): ꢀꢀ¼ 3113 (NH), 1623 (C¼N) cmꢀ1
;
1H NMR (CDCl3): ꢁ ¼ 6.72 (s, thiazole-H5), 7.12–7.89
(m, 15Ar–H), 7.98 (s, pyrazole-H5), 8.3 (s, CH¼N), 9.6
(s, NH) ppm.
2-((1-Phenyl-3-p-tolyl-1H-pyrazol-4-yl)methylene)-1-(4-
phenylthiazol-2-yl)-hydrazine (11b, C26H21N5S)
Brown powder; yield 0.85 g (98%); mp 150–151ꢁC;
Preparation of thiosemicarbazones derivatives 10a–10c
A mixture of 273 mg thiosemicarbazide (3 mmol) and the
appropriate aldehydes 9 (3mmol) was ball-milled at room
temperature for 1 h. The solid products that formed were col-
lected and dried at 0.01 bar at 80ꢁC in vacuum.
IR (KBr): ꢀꢀ¼ 3112 (NH), 1622 (C¼N) cmꢀ1
;
1H NMR
(DMSO-d6): ꢁ ¼ 2.45 (s, CH3), 6.76 (s, thiazole-H5), 7.12–
7.80 (m, 14Ar–H, pyrazole-H5), 8.43 (s, CH¼N), 9.65 (s,
NH) ppm; 13C NMR (DMSO-d6): ꢁ ¼ 19.8 (CH3), 105.2
(C5-thiazole), 115.0 (C4-pyrazole), 119.9 (2CHAr), 124.6
(CHAr), 125.5 (CHAr), 126.5 (2CHAr), 127.8 (2CHAr), 128.1
(2CHAr), 129.7 (2CHAr), 129.9 (2CHAr), 134.0 (CAr), 134.5
(CAr), 137.1 (C3-pyrazole), 138.3 (CAr), 140.1 (CAr), 145.0
(C5-pyrazole), 148.6 (CH¼N), 154.2 (C4-thiazole), 168.7
(C2-thiazole) ppm; MS (EI, 70eV): m=z (%) ¼ 468 (Mþ þ 2,
3.8), 466 (Mþ, 75.3), 344 (15.8), 306 (29.3), 264 (45.8), 122
(100), 69 (67.6).
1-((1,3-Diphenyl-1H-pyrazol-4-yl)methylene)thiosemi-
carbazide (10a, C17H15N5S)
Buff powder; yield 0.94 g (98%); mp 228–230ꢁC (Ref. [25]
230ꢁC); IR (KBr): ꢀꢀ¼ 3255–3322 (NH2), 3139 (NH), 1616
1
(C¼N) cmꢀ1; H NMR (DMSO-d6): ꢁ ¼ 7.4–7.92 (m, 10Ar–
H, pyrazole-H5), 8.3 (s, NH2), 9.2 (s, CH¼N), 11.3 (s, NH)
ppm.
1-((1-Phenyl-3-p-tolyl-1H-pyrazol-4-yl)methylene)thiosemi-
carbazide (10b, C18H17N5S)
2-((3-(4-Nitrophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-
1-(4-phenylthiazol-2-yl)-hydrazine (11c, C25H18N6O2S)
Yellow powder; yield 0.91 g (98%); mp 230–231ꢁC;
White powder; yield 0.98g (98%); mp 198–200ꢁC; IR
(KBr): ꢀꢀ¼ 3253–3393 (NH2), 3139 (NH), 1595 (C¼N)
IR (KBr): ꢀꢀ¼ 3121 (NH), 1614 (C¼N) cmꢀ1
;
1H NMR
cmꢀ1
;
1H NMR (CDCl3): ꢁ ¼ 2.43 (s, CH3), 7.3–7.8 (m,
(DMSO-d6): ꢁ ¼ 6.62 (s, thiazole-H5), 7.23–8.30 (m, 14Ar–